Literature DB >> 25944014

Current Perspectives on Novel Drug Delivery Systems and Approaches for Management of Cervical Cancer: A Comprehensive Review.

Umme Hani1, Riyaz Ali M Osmani, Rohit R Bhosale, Hosakote Gurumallappa Shivakumar, Parthasarathi K Kulkarni.   

Abstract

Cervical cancer is uterine cervix carcinoma, the second deadly cancer and has a high incidence and mortality rate. In the developing world conventional treatment strategies such as surgical intervention and chemoradiotherapy are less widely available. Currently cancer research focuses on improving treatment of cervical cancer using various therapies such as gene therapy, recombinant protein therapy, photodynamic therapy, photothermal therapy and delivery of chemotherapeutic agents using nanoparticles, hydrogel and liposomal based delivery systems and also localized delivery systems which exist in a variety of forms such as intravaginal rings, intravaginal patches, intravaginal films, etc. in order to improve the drug delivery in a controlled manner to the diseased site thereby reducing systemic side effects. The present review encloses existing diverse delivery systems and approaches intended for treatment of cervical cancer.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 25944014     DOI: 10.2174/1389450116666150505154720

Source DB:  PubMed          Journal:  Curr Drug Targets        ISSN: 1389-4501            Impact factor:   3.465


  2 in total

1.  Co-delivery of paclitaxel and TOS-cisplatin via TAT-targeted solid lipid nanoparticles with synergistic antitumor activity against cervical cancer.

Authors:  Bo Liu; Li Han; Junyan Liu; Shumei Han; Zhen Chen; Lixi Jiang
Journal:  Int J Nanomedicine       Date:  2017-01-31

Review 2.  Possible role of nanocarriers in drug delivery against cervical cancer.

Authors:  Swati Gupta; Manish K Gupta
Journal:  Nano Rev Exp       Date:  2017-07-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.